Ren Zhao, Prof1, Zijia Song, DR1, Kun Liu, DR2, Yimei Jiang, DR2, You Li, DR2, Yiqing Shi, DR2, Xi Cheng, DR1, Haoxuan Wu, DR1. 1Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 2Department of General surgery, Ruijin Hospital North, Shanghai Jiaotong University School of Medcine
Purpose: Conventional 5 incision laparoscopic surgery procedure for colorectal cancer is widely accepted as a successful alternative to laparotomy now, bestowing specific advantages without causing detriment to oncological outcome. Evolving from this, “scarless” surgery has become a focus, single-incision laparoscopic surgery (SILS) is attracting increasing attention. After nearly 10 years’ development, SILS for colorectal cancer is still in early stage. In this study, we aim to evaluated the possibility and safety of single-incision laparoscopic surgery for colorectal cancer.
Methods: From September 2013 to June 2017, a total of 122 patients underwent single-incision laparoscopic surgery for colorectal cancer. Data on short-term clinical and oncological outcomes were collected prospectively and reviewed.
Results: In total, there were 122 patients (70 men and 52 women) with a mean age of 61.17 years (range, 33–83). 101 operations were accomplished successfully with single-incision laparoscopy surgery for colorectal cancer, 18 patients (14.8%) were converted to multiport approach, and 3(2.4%) was converted to laparotomy. 12 patients underwent low anterior resection, while 9 of them were converted to multiport approach. The average operative time was(133.37±44.26)min, with an average blood loss of (73.85±110.56) ml, the median postoperative hospital stay was (9.54±2.06)days. All patients received a R0 resection and the surgical margin were conformed negative in all 122 cases, the median number of harvested lymph node is (17.74±6.81), the proximal resection margin is(6.49±4.06)cm and the distal resection margin is(5.44±3.78)cm. There were 5 postoperational complications(4%), no operation-related mortality or postoperative anastomotic leakage was observed.
Conclusions: SILS for colorectal cancer is feasible and can be safely performed with acceptable short-term clinical and oncological outcome.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 91029
Program Number: ETP861
Presentation Session: Emerging Technology iPoster Session (Non CME)
Presentation Type: Poster